Lung Cancer News and Research

Latest Lung Cancer News and Research

Revised guidelines perpetuate racial and ethnic disparities in lung cancer screening eligibility

Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

22 Sep 2021

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers respond to these immune treatments, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy.

22 Sep 2021

Hispanic Americans have a higher risk of preventable infection-related cancers, report shows

A new report shows that although Hispanic men and women in the continental United States and Hawaii have 25% to 30% lower overall cancer incidence and mortality than non-Hispanic Whites, they continue to have a higher risk of potentially preventable, infection-related cancers, including approximately two-fold higher rates of liver and stomach cancers.

21 Sep 2021

Artificial intelligence predicts the risk of metastatic relapse in breast cancer patients

The RACE AI study conducted by Gustave Roussy and the startup Owkin, as part of the AI for Health Challenge organized by the Ile-de-France Region in 2019, was presented as a proffered paper at ESMO.

21 Sep 2021

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

Scientists from the University of Oxford and the Ludwig Institute for Cancer Research are building on the success of the Oxford-AstraZeneca vaccine against SARS-CoV-2 to develop a vaccine to treat cancer.

21 Sep 2021

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology (ESMO Congress 2021), the leading professional society for medical oncology.

20 Sep 2021

Study uncovers a new way to counter immune suppression in tumors

Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian has uncovered a new way to counter this immunosuppressive effect.

20 Sep 2021

Study quantifies the life-years lost to cancer among transplant recipients

People who have received organ transplants face an elevated risk of developing cancer, primarily due to immunosuppression from medications to prevent organ rejection, as well as underlying medical conditions.

20 Sep 2021

Novel drug combinations improve progression-free survival for patients with advanced NSCLC

New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer (NSCLC).

18 Sep 2021

Covid-overwhelmed hospitals postpone cancer care and other treatment

It's a bad time to get sick in Oregon. That's the message from some doctors, as hospitals fill up with covid-19 patients and other medical conditions go untreated.

17 Sep 2021

Owlstone Medical appoints Mark Capone to board of directors

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the appointment of Mark Capone, former President and CEO of Myriad Genetics to its Board as an independent non-executive director.

From Owlstone Medical Ltd 17 Sep 2021

Study highlights the importance of deeply exploring the immune responses against cancer

Over the past decade, scientists have been exploring vaccination as a way to help fight cancer. These experimental cancer vaccines are designed to stimulate the body's own immune system to destroy a tumor, by injecting fragments of cancer proteins found on the tumor.

16 Sep 2021

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

Months after Kyle Dixon died, his old house in Lanse, Pennsylvania, is full of reminders of a life cut short.

16 Sep 2021

Grouping EGFR mutations provides an accurate way to match lung cancer patients to the right drugs

Researchers from The University of Texas MD Anderson Cancer Center have discovered that grouping epidermal growth factor receptor (EGFR) mutations by structure and function provide an accurate framework to match patients with non-small cell lung cancer (NSCLC) to the right drugs.

16 Sep 2021

Low-dose CT lung cancer screening linked to reduction in lung cancer mortality

Low-dose CT lung cancer screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared against a non-LDCT control arm, according to research presented by Professor John Field and the United Kingdom Cancer Screening Trial (UKLS) Team today at the IASLC 2021 World Conference on Lung Cancer. The research will be published in the Lancet Regional Health-Europe.

13 Sep 2021

Survey: Nearly two-thirds of thoracic oncologists used telehealth for the first time during pandemic

Nearly two-thirds of thoracic oncologists surveyed indicated they used telehealth tools for the first time during the COVID-19 pandemic, according to a report issued at the IASLC 2021 World Conference on Lung Cancer.

12 Sep 2021

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Neoadjuvant cisplatin and pemetrexed plus atezolizumab followed by surgical resection and maintenance atezolizumab met safety criteria, according to research presented today in OA13: Topics in Pleural Mesothelioma at the IASLC 2021 World Conference on Lung Cancer.

12 Sep 2021

Lung Cancer News and Research

Latest Lung Cancer News and Research

Revised guidelines perpetuate racial and ethnic disparities in lung cancer screening eligibility

Study findings could lead to novel ways to overcome tumor resistance to immunotherapies

Hispanic Americans have a higher risk of preventable infection-related cancers, report shows

Artificial intelligence predicts the risk of metastatic relapse in breast cancer patients

Oxford COVID vaccine technology has the potential to revolutionize cancer treatment

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

Study uncovers a new way to counter immune suppression in tumors

Study quantifies the life-years lost to cancer among transplant recipients

Novel drug combinations improve progression-free survival for patients with advanced NSCLC

Covid-overwhelmed hospitals postpone cancer care and other treatment

Owlstone Medical appoints Mark Capone to board of directors

Study highlights the importance of deeply exploring the immune responses against cancer

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

Grouping EGFR mutations provides an accurate way to match lung cancer patients to the right drugs

Low-dose CT lung cancer screening linked to reduction in lung cancer mortality

Survey: Nearly two-thirds of thoracic oncologists used telehealth for the first time during pandemic

Neoadjuvant CPA followed by surgical resection and maintenance atezolizumab meets safety criteria

Study finds significant variability in treatment access for patients with malignant pleural mesothelioma

Lung cancer patients report high anxiety levels and experience treatment delays due to the pandemic

Study shows how oncology practices changed after durvalumab approval for unresectable stage III NSCLC patients

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in